Q2 2025 CRO Activity and Intel Report - Identify Leading CROs and Sponsors with the Most Active Presence
Written by Emily J. Thompson, Senior Investment Analyst

Source: Yahoo Finance
Updated: 08-081mins
CRO Activity Insights: The Q2 2025 CRO Activity and Intel report provides detailed analysis of trends in the contract research organization industry, including geographical performance, leading CROs and sponsors, and the most studied therapeutic areas.
Clinical Trial Developments: The report highlights clinical trial activities across North America, Europe, and other regions, comparing data from Q2 2025 to Q2 2024, with a focus on oncology and CNS trials.
About the author

Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Top News
Related Articles
People Also Watch

UPS
United Parcel Service Inc
88.820
USD
+3.10%

STHO
Star Holdings
8.530
USD
+5.31%

NGS
Natural Gas Services Group Inc
26.680
USD
+3.13%

DOUG
Douglas Elliman Inc
2.660
USD
+6.83%

ALTG
Alta Equipment Group Inc
8.020
USD
+10.16%

FHB
First Hawaiian Inc
25.510
USD
+3.66%

OBIO
Orchestra Biomed Holdings Inc
2.550
USD
+2.41%

PBT
Permian Basin Royalty Trust
16.450
USD
+4.91%

CMBT
CMB.TECH NV
8.430
USD
+1.57%